FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Why Zero Based Budgeting Is Popular explains its straightforward approach and strong results for disciplined spenders.
22,446 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
As Guidewire charts its path through cloud adoption and insurer modernization, guidewire (gwre) 2026 earnings become ...
Investors eye Hewlett Packard Enterprise’s 2026 earnings call for guidance on AI demand, GreenLake growth, and capita...
Bittensor's TAO aims to blend AI training services with blockchain incentives. After a sharp rally, investors wonder ...
A seasoned wealth manager reduces its IBTG stake in a move that signals routine rebalancing, not a retreat from bonds...
CrossCountry Mortgage plans a pro rata quarterly dividend for Two Harbors shareholders in the deal closing quarter, a...
Chipotle faced a surprising dip in customer visits across all four quarters of 2025. This analysis breaks down the dr...
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
When the market shakes off retail names, patient investors can spot opportunities. Here are two retail growth stocks ...
A major insider purchase often sparks questions about a stock's future. This breakdown examines what the 125,000-shar...
When rates stay elevated, not all financial stocks rise with them. This guide highlights the sectors and strategies m...
In a world of slim yields, five dividend stocks yielding more than 5% offer a chance for meaningful passive income. T...